147 related articles for article (PubMed ID: 38780974)
1. Symposium review: high altitude travel with pulmonary vascular disease.
Titz A; Schneider S; Mueller J; Mayer L; Lichtblau M; Ulrich S
J Physiol; 2024 May; ():. PubMed ID: 38780974
[TBL] [Abstract][Full Text] [Related]
2. Clinician's Corner: Counseling Patients with Pulmonary Vascular Disease Traveling to High Altitude.
Ulrich S; Lichtblau M; Schneider SR; Saxer S; Bloch KE
High Alt Med Biol; 2022 Sep; 23(3):201-208. PubMed ID: 35852848
[TBL] [Abstract][Full Text] [Related]
3. Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial.
Schneider SR; Mayer LC; Lichtblau M; Berlier C; Schwarz EI; Saxer S; Tan L; Furian M; Bloch KE; Ulrich S
ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34651040
[TBL] [Abstract][Full Text] [Related]
4. Can patients with pulmonary hypertension travel to high altitude?
Luks AM
High Alt Med Biol; 2009; 10(3):215-9. PubMed ID: 19775210
[TBL] [Abstract][Full Text] [Related]
5. Oxygen Therapy in Pulmonary Vascular Disease: A Systematic Review, Meta-Analysis, and Comment.
Schuster M; Müller J; Schwarz EI; Saxer S; Schneider SR; Ulrich S; Lichtblau M
Heart Fail Clin; 2023 Jan; 19(1S):e1-e11. PubMed ID: 36922056
[TBL] [Abstract][Full Text] [Related]
6. Altitude exposure in pediatric pulmonary hypertension-are we ready for (flight) recommendations?
Herberg U; Knies R; Müller N; Breuer J
Cardiovasc Diagn Ther; 2021 Aug; 11(4):1122-1136. PubMed ID: 34527538
[TBL] [Abstract][Full Text] [Related]
7. The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial.
Müller J; Titz A; Schneider SR; Bauer M; Mayer L; Lüönd L; Ulrich T; Furian M; Forrer A; Schwarz EI; Bloch KE; Lichtblau M; Ulrich S
Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38423623
[TBL] [Abstract][Full Text] [Related]
8. Right ventricular performance during acute hypoxic exercise.
Forbes LM; Bull TM; Lahm T; Sisson T; O'Gean K; Lawley JS; Hunter K; Levine BD; Lovering A; Roach RC; Subudhi AW; Cornwell WK
J Physiol; 2024 Feb; ():. PubMed ID: 38409819
[TBL] [Abstract][Full Text] [Related]
9. Cardiorespiratory Adaptation to Short-Term Exposure to Altitude vs. Normobaric Hypoxia in Patients with Pulmonary Hypertension.
Schneider SR; Lichtblau M; Furian M; Mayer LC; Berlier C; Müller J; Saxer S; Schwarz EI; Bloch KE; Ulrich S
J Clin Med; 2022 May; 11(10):. PubMed ID: 35628896
[TBL] [Abstract][Full Text] [Related]
10. Occupational health of miners at altitude: adverse health effects, toxic exposures, pre-placement screening, acclimatization, and worker surveillance.
Vearrier D; Greenberg MI
Clin Toxicol (Phila); 2011 Aug; 49(7):629-40. PubMed ID: 21861588
[TBL] [Abstract][Full Text] [Related]
11. Do lung disease patients need supplemental oxygen at high altitude?
Luks AM
High Alt Med Biol; 2009; 10(4):321-7. PubMed ID: 20039812
[TBL] [Abstract][Full Text] [Related]
12. Cerebral oxygenation in highlanders with and without high-altitude pulmonary hypertension.
Furian M; Latshang TD; Aeschbacher SS; Ulrich S; Sooronbaev T; Mirrakhimov EM; Aldashev A; Bloch KE
Exp Physiol; 2015 Aug; 100(8):905-14. PubMed ID: 26011291
[TBL] [Abstract][Full Text] [Related]
13. Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension.
Roubinian N; Elliott CG; Barnett CF; Blanc PD; Chen J; De Marco T; Chen H
Chest; 2012 Oct; 142(4):885-892. PubMed ID: 22490871
[TBL] [Abstract][Full Text] [Related]
14. Right-to-left shunts in lowlanders with COPD traveling to altitude: a randomized controlled trial with dexamethasone.
Lichtblau M; Furian M; Aeschbacher SS; Bisang M; Sheraliev U; Mademilov M; Marazhapov NH; Ulrich S; Sooronbaev T; Bloch KE; Ulrich S
J Appl Physiol (1985); 2020 Jan; 128(1):117-126. PubMed ID: 31751183
[TBL] [Abstract][Full Text] [Related]
15. The independent effects of hypovolaemia and pulmonary vasoconstriction on ventricular function and exercise capacity during acclimatisation to 3800 m.
Stembridge M; Ainslie PN; Boulet LM; Anholm J; Subedi P; Tymko MM; Willie CK; Cooper SM; Shave R
J Physiol; 2019 Feb; 597(4):1059-1072. PubMed ID: 29808473
[TBL] [Abstract][Full Text] [Related]
16. Counseling Patients with Chronic Obstructive Pulmonary Disease Traveling to High Altitude.
Bloch KE; Sooronbaev TM; Ulrich S; Lichtblau M; Furian M
High Alt Med Biol; 2023 Sep; 24(3):158-166. PubMed ID: 37646641
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F
Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213
[TBL] [Abstract][Full Text] [Related]
18. Lung disease at high altitude.
Stream JO; Luks AM; Grissom CK
Expert Rev Respir Med; 2009 Dec; 3(6):635-50. PubMed ID: 20477353
[TBL] [Abstract][Full Text] [Related]
19. Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension.
Groth A; Saxer S; Bader PR; Lichtblau M; Furian M; Schneider SR; Schwarz EI; Bloch KE; Ulrich S
Int J Cardiol; 2018 Nov; 270():262-267. PubMed ID: 29891241
[TBL] [Abstract][Full Text] [Related]
20. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness.
Penaloza D; Arias-Stella J
Circulation; 2007 Mar; 115(9):1132-46. PubMed ID: 17339571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
